纳布啡联合右美托咪定对腹腔镜输尿管取石术后镇痛和炎症因子水平的影响  被引量:2

Effect of nalbuphine combined with dexmedetomidine on postoperative analgesia and inflammatory factors after laparoscopic ureterolithotomy

在线阅读下载全文

作  者:孙鹏[1] 栾慧 尹青梅[3] 王伟民 蓝海宏 Sun Peng;Luan Hui;Yin Qingmei;Wang Weimin;Lan Haihong(Department of Anesthesiology,Laiyang Central Hospital,Yantai 265200,China;Department of Radiology,Laiyang Central Hospital,Yantai 265200,China;Department of Pain,Yantai Laiyang Central Hospital,Yantai 265200,China;Department of Urology,Laiyang Central Hospital,Yantai 265200,China)

机构地区:[1]烟台市莱阳中心医院麻醉科,烟台265200 [2]烟台市莱阳中心医院放射科,烟台265200 [3]烟台市莱阳中心医院疼痛科,烟台265200 [4]烟台市莱阳中心医院泌尿外科,烟台265200

出  处:《中国临床实用医学》2023年第3期48-53,共6页China Clinical Practical Medicine

基  金:烟台市科技计划项目(2022YD)。

摘  要:目的探讨纳布啡联合右美托咪定对腹腔镜输尿管取石术(LU)后镇痛和炎症因子的影响。方法本研究为随机对照研究,选取2020年1—6月烟台市莱阳中心医院泌尿外科收治的92例行LU的患者,男49例,女43例,年龄(38.6±14.9)岁,年龄范围为22~62岁。采用随机数表法将患者随机分为纳布啡组与联合麻醉组,每组46例。比较两组患者从进入恢复室至术后4、12、24、48 h的视觉模拟评分(VAS)及Ramsay镇静评分,术后1、2、3 d最大疼痛VAS,住院期间每日平均艾瑞昔布用量,患者术后满意度(10分满分),血清白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)水平及术后镇痛不良反应。结果联合麻醉组术后4、12、24 h静息VAS[(2.1±0.5)分、(2.7±0.4)分、(3.1±0.4)分]低于纳布啡组[(2.7±0.3)分、(3.1±0.2)分、(3.6±0.3)分],活动VAS[(2.8±0.4)分、(3.3±0.4)分、(3.5±0.3)分]低于纳布啡组[(3.4±0.2)分、(3.6±0.2)分、(3.7±0.4)分],静息Ramsay镇静评分[(2.0±0.3)分、(2.3±0.3)分、(3.0±0.4)分]低于纳布啡组[(2.5±0.5)分、(2.6±0.4)分、(3.3±0.3)分],活动Ramsay镇静评分[(2.8±0.3)分、(3.3±0.3)分、(3.4±0.3)分]低于纳布啡组[(3.2±0.2)分、(3.6±0.2)分、(3.7±0.4)分],术后1、2、3 d最大疼痛VAS[(3.7±0.4)分、(3.5±0.6)分、(2.9±0.4)分]低于纳布啡组[(3.9±0.3)分、(3.8±0.4)分、(3.3±0.5)分],住院期间每日平均艾瑞昔布用量(60 mg)少于纳布啡组(100 mg),患者满意度评分[(9.5±0.4)分]高于纳布啡组[(8.9±0.7)分],差异均有统计学意义(P<0.05)。术后联合麻醉组IL-6[(150.33±19.16)pg/ml]、TNF-α[(38.21±4.78)pg/ml]及CRP水平[(6.74±0.28)mg/ml]均低于纳布啡组[(269.85±27.76)pg/ml、(61.95±6.72)pg/ml、(7.82±0.51)mg/ml],差异有统计学意义(P<0.05)。联合麻醉组不良反应总发生率[30.4%(14/46)]低于纳布啡组[58.7%(27/46)],差异有统计学意义(P<0.05)。结论纳布啡联合右美托咪定对LU进行患者自控镇痛,术后镇痛效�Objective To explore the effect of nalbuphine combined with dexmedetomidine on analgesia and inflammatory factors after laparoscopic ureterolithotomy(LU).Methods This study was a randomized controlled study.A total of 92 patients,including 49 males and 43 females,aged(38.6±14.9)years old,ranging from 22 to 62 years old underwent LU in department of Urology in Yantai Laiyang Central Hospital from January to June 2020 were selected.The patients were randomly divided into nalbuphine group and combined anesthesia group by random number table,there were 46 cases in each group.visual analogue scale(VAS)score and Ramsay sedation score were compared between the two groups from entering the recovery room to 4,12,24 and 48 h after surgery,the maximal pain VAS was obtained at 1,2 and 3 d after operation,average daily icrecoxib dosage during hospitalization,postoperative satisfaction(10 full points),serum interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),C-reactive protein(CRP)levels,and postoperative analgesic adverse reactions.Results Combined anesthesia group had lower resting VAS score[(2.1±0.5)points,(2.7±0.4)points,(3.1±0.4)points]at 4,12 and 24 h after operation than nalbuphine group[(2.7±0.3)points,(3.1±0.2)points,(3.6±0.3)points],activity VAS score[(2.8±0.4)points,(3.3±0.4)points,(3.5±0.3)points]than nalbuphine group[(3.4±0.2)points,(3.6±0.2)points,(3.7±0.4)points],and lower resting Ramsay sedation score[(2.0±0.3)points,(2.3±0.3)points,(3.0±0.4)points]than nalbuphine group[(2.5±0.5)points,(2.6±0.4)points,(3.3±0.3)points],The Ramsay sedation score of activity[(2.8±0.3)points,(3.3±0.3)points,(3.4±0.3)points]was lower than that of nalbuphine group[(3.2±0.2)points,(3.6±0.2)points,(3.7±0.4)points],the VAS score of maximum pain at 1,2 and 3 d after surgery[(3.7±0.4)points,(3.5±0.6)points,(2.9±0.4)points]was lower than that of nalbuphine group[(3.9±0.3)points,(3.8±0.4)points,(3.3±0.5)points],and the average daily dosage of icoxib during hospitalization(60 mg)was less than that of nalbuphin

关 键 词:纳布啡 右美托咪定 腹腔镜输尿管取石术 术后镇痛 

分 类 号:R699.4[医药卫生—泌尿科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象